Type
. Immunoprophylaxis of leprosy: current status and future prospects. Indian journal of dermatology, venereology and leprology. 2007;73(2):71-2.
Type
. Neretva Valley: from leprosarium to nature park. Croatian medical journal [Internet]. 2007;48(2):256-8. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2080527/pdf/CroatMedJ_48_0256.pdf
Type
. How leprosy is depicted in Ben-Hur. International journal of dermatology. 1991;30(11):818-24.
Type
. Characterization of circulating lymphocytes by monoclonal antibodies in childhood and adult leprosy. International journal of dermatology. 1991;30(11):780-4.
Type
. Pre-emptive diagnosis of leprosy. International journal of dermatology. 1991;30(11):767-71.
Type
. Gallium scintigraphy in Hansen's disease. European journal of nuclear medicine. 1991;18(11):866-9.
Type
. Differentiation of patients with leprosy from non-infected individuals by the chemokine eotaxin/CCL11. The American journal of tropical medicine and hygiene. 2007;77(3):547-50.
Type
. Ninjurin 1 asp110ala single nucleotide polymorphism is associated with protection in leprosy nerve damage. Journal of neuroimmunology. 2007;190(1-2):131-8.
Type
. Report of the workshop on the use of chemoprophylaxis in the control of leprosy held in Amsterdam, The Netherlands on 14 December 2006. Leprosy review [Internet]. 2007;78(2):173-85. Available from: https://leprosyreview.org/article/78/2/17-3185
Type
. 'Leprosy elimination'--need for sample survey. Leprosy review [Internet]. 2007;78(2):167-9. Available from: https://leprosyreview.org/article/78/2/16-7169